Compounds and methods for kinase modulation, and indications therefor
Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
1. A method for treating a subject with a B-Raf mediated disease or condition, said method comprising administering to said subject an effective amount of a compound of formula:
or a pharmaceutically acceptable salt or stereoisomer thereof,
wherein:
each R 11 is independently halogen;
Q is H or F;
and
m is 0, 1 or 2,
wherein the B-Raf mediated disease or condition is melanoma, colon cancer, thyroid cancer, ovarian cancer, non-small-cell lung cancer, hepatocellular carcinoma, gastrointestinal stromal cell tumors, multiple myeloma, chronic myeloid leukemia, acute myeloid leukemia, or glioma.
2. The method of claim 1 , wherein R 11 is fluoro.
3. The method of claim 1 , wherein Q is H.
4. The method of claim 1 , wherein Q is fluoro.
5. The method of claim 1 , wherein m is 0.
6. The method of claim 1 , wherein m is 1.
7. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
8. The method of claim 1 , wherein said disease or condition is melanoma.
9. The method of claim 1 , wherein said disease or condition is non-small cell lung cancer.
10. The method of claim 1 , wherein said disease or condition is colon cancer.